RIVERSIDE METHODIST HOSPITAL — History
CCN 360006 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$1.7B
Latest Revenue (FY2022)
+3.5%
Revenue CAGR (3yr)
3.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.6B | $1.7B | $1.7B | +1.5% | +3.5% |
| Operating Expenses | $1.4B | $1.5B | $1.6B | +9.3% | +9.6% |
| Operating Margin | 14.0% | 10.4% | 3.4% | -66.9% | -50.3% |
| Net Income | $222M | $174M | $59M | -66.4% | -48.6% |
| Licensed Beds | 759 | 758 | 743 | -2.0% | -1.1% |
| Total Patient Days | 203,588 | 217,138 | 221,488 | +2.0% | +4.3% |
| Medicare Day % | 27% | 24% | 23% | -3.9% | -7.2% |
| Medicaid Day % | 5% | 6% | 7% | +17.6% | +21.9% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +7.1% ($1.6B → $1.7B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.5%
This Hospital
+7.6%
State Avg
Latest Margin
3.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.8B | -1.8% |
| FY2024 (proj) | $1.8B | -7.1% |
| FY2025 (proj) | $1.9B | -12.3% |